Priser
Platform
Blog
Om os
Download
002038
Beijing SL Pharmaceutical Co
Shenzhen Stock Exchange (Hong Kong)
0

Om

Beijing SL Pharmaceutical Co., Ltd. is an esteemed entity within the pharmaceutical manufacturing sector. The company's primary focus lies in the research, development, production, and marketing of pharmaceutical products that serve the healthcare sector. Known for its commitment to innovation and quality, it produces a wide array of medications covering various therapeutic areas, including cardiovascular, digestive, and metabolic disorders. The firm operates under rigorous adherence to international standards, ensuring its products meet the highest safety and efficacy criteria. Beijing SL Pharmaceutical significantly contributes to the pharmaceutical supply chain, extending its reach not only domestically but also in select international markets through strategic partnerships and exports. Its role in the financial market is marked by its continuous investment in R&D, aiming to deliver advanced medicinal solutions. The company plays a vital part in addressing diverse healthcare needs, reinforcing its presence in both clinical and consumer health spaces.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I BEIJING SL PHARMACEUTICAL CO MED ENDAVU: Køb Beijing SL Pharmaceutical Co ($002038) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Beijing SL Pharmaceutical Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

Ticker002038
Land
Kina
Antal medarbejdere889
Hjemmesideslpharm.com.cn
SektorSundhed
IndustriLægemiddelproducenter - Specialitet og generisk

Udbytter

0,2CNH
'20
0,1CNH
'21
0,1CNH
'22
0,1CNH
'23
0,15CNH
'24
0,02CNH
'25
Ex-udbytte-dato4. jul. 2025
Udbytteafkast0,31%